Bridgewater Associates LP decreased its holdings in STERIS plc (NYSE:STE - Free Report) by 30.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,968 shares of the medical equipment provider's stock after selling 4,773 shares during the quarter. Bridgewater Associates LP's holdings in STERIS were worth $2,255,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in STE. Principal Financial Group Inc. raised its stake in shares of STERIS by 9.5% in the 3rd quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock valued at $270,230,000 after buying an additional 96,336 shares in the last quarter. SkyView Investment Advisors LLC increased its position in shares of STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock worth $765,000 after purchasing an additional 51 shares in the last quarter. World Investment Advisors LLC acquired a new stake in shares of STERIS during the 3rd quarter worth about $5,171,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of STERIS during the 3rd quarter worth about $9,949,000. Finally, Tidal Investments LLC increased its position in shares of STERIS by 21.0% during the 3rd quarter. Tidal Investments LLC now owns 12,650 shares of the medical equipment provider's stock worth $3,068,000 after purchasing an additional 2,193 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.
STERIS Stock Up 1.4 %
Shares of STERIS stock traded up $3.09 during trading hours on Thursday, reaching $226.96. 65,492 shares of the company's stock were exchanged, compared to its average volume of 524,235. The company has a 50 day moving average of $222.65 and a two-hundred day moving average of $218.97. STERIS plc has a fifty-two week low of $200.41 and a fifty-two week high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The stock has a market cap of $22.30 billion, a P/E ratio of 48.19 and a beta of 0.87.
STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.
STERIS Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.00%. STERIS's dividend payout ratio (DPR) is presently 48.41%.
Analyst Ratings Changes
Several equities research analysts have weighed in on STE shares. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Monday, April 7th. JMP Securities reiterated a "market outperform" rating and set a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Finally, Stephens reiterated an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, STERIS has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.
Check Out Our Latest Analysis on STE
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Stories
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
